| Application no. and date | 01922629.9 (espacenet) (Federated) (European Patent Register), 20010323 | | Patent/reg. no. and date | DK/EP 1265929, 20090708 | | Publication date | 20021218 | | Priority no. and date | US 191429 P, 20000323 | | EP pub. no. and date |
EP 1265929 20021218 | | Effective date | | | Applicant/owner | Genentech, Inc., 1 DNA Way
South San Francisco,
CA 94080, US | | Applicant ref. no. | 153067 | | Inventor | FUNG, Michael, 3511 Deal
Houston, TX 77025, US,
SUN, William, N., 4901 Welford Drive
Bellaire, TX 77041, US,
SUN, Cecily, 4901 Welford Drive
Bellaire, TX 77041, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 7/00 (2006.01) , C07K 16/40 (2006.01) , C12N 5/12 (2006.01) , G01N 33/577 (2006.01) | | Title | Anti-C2/C2a-inhibitorer til komplement aktivering | | Int. application no. | US2001009409 | | Int. publication no. | WO2001070818 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
